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Abstract
The complex physiopathological events occurring after spinal cord injury (SCI) make this devastating trauma still incurable.
Self-assembling peptides (SAPs) are nanomaterials displaying some appealing properties for application in regenerative
medicine because they mimic the structure of the extra-cellular matrix (ECM), are reabsorbable, allow biofunctionalizations
and can be injected directly into the lesion. In this study we evaluated the putative neurorigenerative properties of RADA16-
4G-BMHP1 SAP, proved to enhance in vitro neural stem cells survival and differentiation. This SAP (RADA16-I) has been
functionalized with a bone marrow homing motif (BMHP1) and optimized via the insertion of a 4-glycine-spacer that
ameliorates scaffold stability and exposure of the biomotifs. We injected the scaffold immediately after contusion in the rat
spinal cord, then we evaluated the early effects by semi-quantitative RT-PCR and the late effects by histological analysis.
Locomotor recovery over 8 weeks was assessed using Basso, Beattie, Bresnahan (BBB) test. Gene expression analysis showed
that at 7 days after lesion the functionalized SAP induced a general upregulation of GAP-43, trophic factors and ECM
remodelling proteins, whereas 3 days after SCI no remarkable changes were observed. Hystological analysis revealed that 8
weeks after SCI our scaffold increased cellular infiltration, basement membrane deposition and axon regeneration/sprouting
within the cyst. Moreover the functionalized SAP showed to be compatible with the surrounding nervous tissue and to at
least partially fill the cavities. Finally SAP injection resulted in a statistically significant improvement of both hindlimbs’
motor performance and forelimbs-hindlimbs coordination. Altogether, these results indicate that RADA16-4G-BMHP1
induced favourable reparative processes, such as matrix remodelling, and provided a physical and trophic support to
nervous tissue ingrowth. Thus this biomaterial, eventually combined with cells and growth factors, may constitute a
promising biomimetic scaffold for regenerative applications in the injured central nervous system.
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Introduction
Regenerative medicine features the valuable potential to cure a
broad range of diseases and injuries, including the degeneration of
central nervous system (CNS), in which the progressive death of
nervous cells results in permanent disabilities and/or cognitive
deficits. Spinal cord injuries (SCI) are among the most devastat-
ing pathologies of CNS, leading to partial or complete loss of
respiratory, autonomic and sensory-motor functions [1]. In spite of
the growing knowledge of the processes involved in SCI, the
treatments available for these patients are still unable to restore the
lost functions and are mainly limited to the administration of anti-
inflammatory agents (i.e. methylprednisolone), surgical decompres-
sion of spinal cord, stabilization of vertebral column, rehabilitation
and functional electrical stimulation (FES) [2,3,4]. The poor
outcome of therapies aiming to cure SCI is due to the complexity
of the physiopathological events that occur after this trauma. These
unfavourable events, including invasion of inflammatory and glial
cells, secretion of inhibitors of axon growth, ongoing apoptosis of
neural cells and demyelination and formation of cavities or cysts,
culminate in glial scarring and loss of the complex nervous
cytoarchitecture [5,6,7]. To contrast these processes and favour
neuroprotection and/or nervous tissue regeneration, over the past
decades various strategies have been proposed, including cell
transplantation, scaffold implantation, drug delivery and rehabilita-
tive training [5,8,9].
Up to now, cellular transplantation alone led to moderate
sensory and motor improvements in animal models of SCI and
failed in reconstituting a functional tissue in large lesions because
the area of cyst and glial scarring constitutes a gap and a physical
barrier to regeneration [10,11]. In order to bridge the tissue defect,
various biomaterials, either naturally derived or synthetic, have
been tested [12]. Hydrogels are biomaterials characterized by a
porous network of polymeric nano- and microfibers featuring
three-dimensional (3D) microenvironments in vitro and in vivo [13].
Common naturally derived hydrogel materials used in stem cell-
based research and in experimental models of SCI include
collagen [14], hyaluronic acid [15], methylcellulose [16] and
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Even if these biomaterials showed to support axon regeneration
and myelination and to reduce cavity formation, synthetic
polymers permit to more easily and precisely adjust key
parameters of the scaffold (3D architecture, porosity, stiffness,
degradation rate, etc) and to add functionalizations [13]. Scaffold
modifications with functional motifs can be useful for enhancing
cell adhesion [19], achieving slow release of molecules and/or cells
[20,21], controlling the spatiotemporal differentiation of trans-
planted stem cells [22,23,24] and for ameliorating the biocom-
patibility of the implant [25,26].
Among the most used synthetic hydrogels there are self-
assembling peptides (SAPs). They are composed of short, repeating
units of amino acids that form nanofibrous scaffolds in response to
thermal or pH changes [27]. The ability to form a rigid scaffold
only at physiological pH or specific salt concentrations makes
SAPs appealing for application in SCI because they can be
injected directly into the lesion site, then minimizing the damage
brought to the cord by scaffold implantation surgery. At
microscopic level SAPs mimic the porosity and the nanostructure
of the extra-cellular matrix (ECM), thus permitting the cells to
reside in a 3D environment; moreover, they allow biofunctiona-
lizations suited for the desired application [28]. Thanks to these
properties, SAPs-based scaffolds have been successfully used for a
large variety of applications, including 3D cell cultures [29], tissue
engineering [30] and regenerative medicine applications [31]. The
most commonly employed SAP is RADA16-I [27,31,32].
We previously demonstrated that RADA16-I, functionalized
with the sequence PFSSTKT, significantly enhanced in vitro
survival and differentiation of adult mouse neural stem cells (NSC)
[33].
PFSSTKT (BMHP1) belongs to a class of bone marrow homing
peptides (BMHP) that were identified by applying the phage
display methodology to the bone marrow and stem cells: Becker
and colleagues found a family of heptapeptides -mainly consisting
of lysine, proline, phenylalanine, two serines and two threonines-
which specifically homed to bone marrow and bound to primitive
hematopoietic stem cells [34]. Even if function of the sequence
PFSSTKT still remains to be elucidated, its observed biological
effect on NSCs is probably due to the sharing of some
differentiating pathways and adhesion receptors between bone
marrow stem cells and NSCs [35].
Recently we showed that RADA16-I functionalized with
BMHP1 fostered conspicuous nervous tissue regrowth in chronic
SCI in rats [36]. In this study we injected the SAP, loaded with
cytokines, into electrospun nanofiber channels, then showing that
by engineering SAP-based matrices into neuroprosthetics it is
possible to replace large hollow tissue gaps in the chronically
injured spinal cord.
However, despite these promising results, later on, we
demonstrated that the insertion of four glycines between the self-
assembling core of RADA16-I and the functional motif BMHP1
increased the nanostructure stability of SAPs and the exposure of
the functional motif, improving the in vitro adhesion, viability and
differentiation of mouse NSCs in comparison with functionalized
SAP featuring shorter spacers [37].
In order to evaluate the putative application for neuroregen-
erative purposes of this latter SAP, named RADA16-4G-BMHP1,
we delivered it in the lesion site of acutely contused rat spinal cords
and we evaluated its early and late effects on injured tissues and
motor function recovery. The obtained data showed that the
injection of RADA16-4G-BMHP1 immediately after injury did
not prevent cyst formation but enhanced nervous tissue ingrowth.
RT-PCR assay displayed that the scaffold induced a favourable
matrix remodelling process and provided a physical and trophic
support to tissue regrowth, then resulting in an increased cellular
infiltration and axon regeneration/sprouting, as seen by histolog-
ical analysis at 8 weeks after SCI. Moreover the scaffold proved to
be compatible with the nervous tissue and to ameliorate the
locomotor recovery of animals.
Results
We randomly divided 45 female Sprague-Dawley rats into 3
groups as follows: 1) injured animals (SCI control group);
2) animals receiving contusion and injection of saline solution
(saline control group); 3) animals receiving contusion and injection
of the functionalized SAP (4G-BMHP1 treatment group).
RADA16-I-4G-BMHP1 self-assembling peptide solution (1% w/
v) was sonicated for 30 min prior usage (see methods for details).
Gene expression analysis of early effects induced by the
scaffold after SCI
Early effects induced by the injection of RADA16-I-4G-
BMHP1 at the injury site were assessed by a semi-quantitative
RT-PCR assay. Changes in the mRNA expression of genes
involved in the inflammatory process, secretion of neurotrophic
factors, matrix remodelling, gliosis and nervous tissue repair
(Figure 1A) were evaluated at 3 and 7 days post injury (dpi). Gene
names and characteristics of gene-specific primers are reported in
Table 1.
Several genes involved in the inflammatory response were
analyzed in order to evaluate if the scaffold could attenuate or
enhance the inflammatory events following SCI. These genes
codify for the pro-inflammatory cytokines IL-1b, IL-6, LIF and
TNFa, for TACE and ICE, that are two enzymes involved in the
proteolytic activation of TNFa and IL-1b respectively, and for
iNOS and nNOS, which are two enzymes responsible for the
production of nitric oxide. At 3 dpi there were no significant
differences in mRNA expression of these genes among groups,
with the exception of LIF, that had lower mRNA levels in the 4G-
BMHP1 group in comparison to both control groups (Figure 1Bi).
At 7 dpi, mRNA levels of LIF were similar in all groups, while a
significant increase of the mRNA expression for IL-6, TNFa,
TACE, nNOS and iNOS appeared in the treatment group in
comparison with SCI control group (Figure 1Bii). As the
upregulation of TNFa, iNOS and nNOS was also observed in
the saline control group, we can suppose that this slight increment
of the sub-acute inflammatory response could be due to the
injection procedure. The presence of the biomaterial seemed to
induce a further little increase of the inflammatory response in
comparison with saline-injected group, as showed by the
upregulation of IL-6 and TACE only in the treatment group.
The second group of genes we studied consisted of the neuronal
cytoskeletal protein NFH- the heavy subunit of neurofilaments
(NF)- and GAP-43, which is a phosphoprotein associated with
axonal growth cones and expressed at high levels by neurons
during axon growth [38]; moreover we assessed the mRNA
expression of GFAP, a protein of the cytoskeleton of astrocytes. As
NFH mRNA expression declined at 3 days in both injected groups
(4G-BMHP1 and saline) in comparison with SCI control group
(Figure 1Ci), we can suppose that the needle insertion could have
caused a slight damage of nervous tissue and exacerbated the NF
expression decrease typically seen after SCI [39]. However, at
7 dpi the 4G-BMHP1 group showed higher mRNA levels than
saline-injected and SCI control groups (Figure 1Cii), then
suggesting that already 1 week after injection the scaffold could
have played a role in the regeneration of the injured nervous tissue
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upregulation of GAP-43 mRNA expression that was observed only
in the treatment group (Figure 1Cii). GFAP mRNA levels were
higher in both groups subjected to injection in comparison with
SCI control group, indicating that at 7 dpi this procedure may
induce a bigger gliosis.
Third group of genes we considered included the neurotrophic
factors NGF, NT3, BDNF and CTNF and the growth factors
BMP2 and VEGF. CNTF is involved in CNS neural repair and its
levels have been showed to increase after SCI [41]; BMP2
promotes astrogliogenesis during CNS development and its
expression is upregulated after SCI, then participating to glial
scar formation [42]; VEGF is a potent stimulator of angiogenesis,
moreover it seems to provide a neuroprotective effect on neurons
after injury [43]. At 3 dpi mRNA expression of these genes was
similar -or undetectable- in all groups, with the exception of
VEGF, which was upregulated in 4G-BMHP1 group in
comparison with both control groups (Figure 1Ci). At 7 dpi a
higher mRNA expression of CNTF, BMP2 and VEGF was
observed in the treatment group in comparison with SCI control
group and, for CNTF and BMP2, in comparison with saline
control group too (Figure 1Cii). These data suggest that the
scaffold could stimulate endogenous repair processes via VEGF
and CNTF.
Finally we analysed several genes involved in matrix remodel-
ling. MMP-9 and MMP-2 are metalloproteinases (MMPs)
involved in the neuroinflammation and remodelling of the neural
ECM. After SCI, MMPs are up-regulated and initially they are
involved in the disruption of the blood-spinal cord barrier [44],
successively they participate in regenerative processes like
angiogenesis and axonal sprouting/regrowth [45,46]. MMP-3
and MMP-14 are the proteolytic activators of MMP-9 and MMP-
2 respectively, whereas TIMP-1 and TIMP-2 are two inhibitor
proteins: they bind MMP-9 and MMP-2 respectively and block
their cleavage [47]. THBS-2 is another inhibitor of MMP-2 [47].
At 3 dpi MMP-9 mRNA was more expressed in the 4G-BMHP1
group in comparison with both controls (Figure 1Di). At 7 dpi the
metalloproteinases inhibitors THBS-2 and TIMP-1 were found
downregulated in the treatment group in comparison with SCI
control group or both controls, respectively; in line with these data,
in the treatment group the mRNA levels of the metalloproteinases
activators MMP-14 and MMP-3 were higher than both controls or
only saline group, respectively (Figure 1Dii). Overall these results
suggest that the scaffold promoted the metalloproteinases acti-
vity. It remains to clarify the role of TIMP-2, that was found
upregulated in 4G-BMHP1- and saline-injected groups in com-
parison with SCI control group: even if TIMP-2 inhibits a broad
range of MMPs, some authors have suggested that it may have a
role also as activator of MMP-2 [47].
Hystological analysis of reparative processes induced by
the scaffold
The late effects induced by the injection of RADA16-I-4G-
BMHP1 were assessed by histological analysis of the injury site.
Eight weeks after SCI we quantified the cyst and cavities
dimension, axon sprouting/regeneration and macrophage infil-
tration, moreover we evaluated the vascularisation, gliosis and
axon maturation (see methods for details).
Cyst and cavities extent was measured on hematoxylin-eosin
stained sections (Figure 2Ai). Average area of the whole cyst was
similar in all groups (Figure 2Aii); likewise, no significant
differences were observed among treatment and both control
groups when we measured only the cavities size within the cyst
excluding strands of connective tissue (trabeculae) (Figure 2Aiii).
In order to quantify axon regeneration/sprouting across the cyst
we investigated the presence of GAP-43 positive fibers and we
expressed the relative value of GAP-43 immunopositive area as
percentage of the total cyst area (Figure 2Bi). Interestingly, we
found a significantly greater synthesis of GAP-43 in 4G-BMHP1
group (12.9462.03% of the whole cyst area) in comparison with
saline (6.3361.7% of the whole cyst area) and SCI control
(5.8461.29% of the whole cyst area) groups (Figure 2Bii).
The chronic inflammatory response was evaluated by counting
macrophages into the lesion site (Figure 2Ci). We observed several
infiltrating CD68 immunopositive cells in all groups, indicating
that at this late phase of the injury the scaffold didn’t significantly
affect the host immune response (Figure 2Cii).
The nature of neural fibers infiltrating the cyst was further
investigated in all experimental groups by performing the
immunofluorescent labelling with b-TubIII, a neuronal marker,
MBP, which detects myelin, and SMI-31 and SMI-32, that react
respectively with phosphorylated and nonphosphorylated neuro-
filament H of axons. Within the cyst, the majority of b-TubIII
positive fibers also expressed GAP-43, whereas some of them were
associated with MBP, indicating that myelination occurred at 8
weeks post-treatment. Among GAP-43 positive fibers, the majority
of them expressed SMI-32, even if another part of GAP-43
positive fibers stained with SMI-31, showing that among growing
axons there were both immature (SMI-32
+) [48] and mature (SMI-
31
+) [49] fibers (Figure 3).
The vascularisation was evaluated by performing immunoflu-
orescence staining for the endothelial cell marker vWF and for two
major components of basement membranes, laminin and type IV
collagen. Within the lesion area, the blood vessels infiltration
appeared similar in all groups, but in the 4G-BMHP1 group we
found a greater deposition of laminin and type IV collagen
(Figure 4).
Finally gliosis, that was evaluated by using immunofluorescence
staining for GFAP, resulted similar in all groups at 8 weeks
(Figure 4).
Histological evaluation of cell infiltration and ECM
deposition into the scaffold
Eight weeks after implantation, the scaffold was found in two-
thirds of animals. The biomaterial had a globular appearance and
resulted faintly autofluorescent (asterisks in Figures 3, 4, 5).
Within the implant we noticed several cells and nerve fibers.
The majority of cells stained for Iba1, a marker for microglia,
Figure 1. Gene expression analysis in the acute and subacute phases of spinal cord injury. Semi-quantitative RT-PCR was employed to
evaluate mRNA expression of several genes involved in destructive and reparative processes following SCI (A). The relative expression of genes was
determined by measuring the band intensity and using cyclophilin as housekeeping (relative density). Overall, at 3 days after SCI few differences were
observed among treatment (4G-BMHP1) and both control (saline and SCI control) groups (Bi, Ci, Di); NT3, BDNF and NGF were undetectable in all
groups. At 7 days after SCI there was a general upregulation of inflammatory genes in both injected groups (biomaterial or saline) in comparison with
SCI control group (Bii), while a general mRNA overexpression for GAP-43, neurotrophins, growth factors (Cii) and ECM remodelling proteins (Dii) was
observed only in the treatment group in comparison with one or both control groups; NGF was undetectable in all groups. Values represent means 6
SEM. Significance symbols: * p,0.05, ** p,0.001.
doi:10.1371/journal.pone.0019782.g001
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Gene name Accession n.
1 Primer Sequence 59–39
Amplicon
length (bp) Cycle
2
cyclophilin A XM_345810 F: gacaaagttccaaagacagca 470 22
R: ctgagctacagaaggaatggtttga
interleukin 1 beta (IL1b) NM_031512 F: tcgggaggagacgactctaa 201 33
R: gaaagctgcggatgtgaagt
interleukin 6 (IL6) NM_012589 F: ccggagaggagacttcacag 161 34
R: acagtgcatcatcgctgttc
tumor necrosis factor alpha (TNFa) NM_012675 F: tactgaacttcggggtgatcggtcc 557 35
R: cagagcaatgactccaaagta
caspase 1 (ICE) NM_012762 F: cacattgaagtgcccaagct 245 32
R: tccaagtcacaagaccaggc
ADAM metallopeptidase domain 17 (TACE) NM_020306 F: gttacaactcatgaattggg 372 33
R: gacagtttttacagcaagg
neuronal nitric oxide synthase 1 (nNOS) NM_052799 F: gaataccagcctgatccatgcaa 602 35
R: tcctccaggagggtgtccaccgcatg
inducible nitric oxide synthase 2 (iNOS) NM_012611 F: acctgggaacacctggggatttt 565 32
R: tgggtcttcgggcttcaggtt att
bone morphogenetic protein 2 (BMP2) NM_017178 F: acacagggacacaccaaccat 125 29
R: tgtgaccagctgtgttcatcttg
ciliary neurotrophic factor (CNTF) NM_013166 F: aacacctctgacccttcacc 193 29
R: tgcctcagtcatctcactcc
brain-derived neurotrophic factor (BDNF) NM_012513 F: tcagtggctggctctcatac 214 34
R: aggacggaaacagaacgaac
leukemia inhibitory factor (LIF) NM_022196 F: aacgtggaaaagctatgtgcg 101 33
R: gcgaccatccgatacagctc
nerve growth factor (NGF) XM_227525 F: gcccactggactaaacttcagc 349 34
R: ccgtggctgtggtcttatctc
neurotrophin 3 (NT-3) NM_031073 F: tgcagagcataagagtcacc 269 35
R: aagtcagtgctcggacgtag
vascular endothelial growth factor A (VEGFa) NM_031836 F: ccatgaactttctgctctctt 482 35
R: ggtgagaggtctagttccc
matrix metallopeptidase 9 (MMP9) NM_031055 F: cccaaagacctgaaaacctcc 98 33
R: ttctctcccatcatctgggc
matrix metallopeptidase 3 (MMP3) NM_133523 F: ttgtccttcgatgcagtcag 126 35
R: agacggccaaaatgaagaga
TIMP metallopeptidase inhibitor 1 (TIMP1) NM_053819 F: gtgcacagtgtttccctgtt 103 31
R: ctggtagcccttctcagagc
matrix metallopeptidase 2 (MMP2) NM_031054 F: tacgatgatgaccggaagtgg 101 35
R: gagtgttccagccccatgg
matrix metallopeptidase 14 (MMP14) NM-031056 F: cactgctggacaaggtctg 413 35
R: cctgaggtcatagttcagag
TIMP metallopeptidase inhibitor 2 (TIMP2) NM_021989 F: gcatcacccagaagaagagc 174 32
R: tgatgcaggcaaagaacttg
thrombospondin 2 (THBS2) NM_001169138 F: ggatgtacgtggccaaggg 641 35
R: ctgggtcccagagccaca
glial fibrillary acidic protein (GFAP) NM_017009 F: tacagacaggaggcggatgaagcc 418 27
R: gcatttgcctctccaaggactc
growth associated protein 43 (GAP-43) NM_008083 F: gggagatggctctgctact 482 35
R: agacagggttcaggtggg
neurofilament, heavy polypeptide (NFH) NM_012607 F:atcgctgcttacagaaaactcc 182 29
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indicating the presence of neuronal elements and oligodendrocyte
precursor cells, respectively; astrocytes (GFAP
+) and macrophages
(CD68
+) were mainly found around the implant (Figure 5A, B, C).
Within the scaffold we observed also laminin and type IV collagen
deposition (Figure 5A), that was often associated with axons
(Figure 5D and 5E, arrows). Laminin and type IV collagen
immunopositivity was further associated with specific cells
surrounding axons (Figure 5D and E, arrowheads), probably
ascribable to Schwann cells migrated from dorsal roots [50].
Neural fibers co-stained for GAP-43 and b-TubIII (Figure 6A). Of
note, occasionally these fibers were also positive for MBP,
indicating that myelination occurred in some regenerating axons
(Figure 6B).
Assessment of locomotor improvements induced by the
scaffold after SCI
The progressive locomotor recovery after SCI was followed by
using the Basso, Beattie, Bresnahan (BBB) test [51]. BBB is an
open field behavioural assessment that specifically evaluates
locomotor outcome of rats after thoracic spinal cord contusion.
BBB rating scale ranges from a minimum of 0 (no observable
hindlimbs movements) to a maximum of 21 (plantar stepping,
coordination and trunk stability like healthy rats).
The scaffold induced, starting from 7.5 weeks after injury, a
better improvement of hindlimbs motor recovery compared to
both control groups (Figure 7). Saline and SCI control groups
reached the maximum score (1160.21 and 10.8860.48 respec-
tively) around the 7
th week. In the BBB test the score reached by
control groups corresponds to plantar stepping, occasional or
frequent, without any forelimbs-hindlimbs coordination. BBB
score of saline-injected group are very similar to SCI control
group, suggesting that injection into the spinal cord neither caused
an important damage nor affected locomotor recovery. Rats
treated with RADA16-I-4G-BMHP1 achieved the maximum
score (11.86 60.47) around the 7
th week. The BBB score obtained
by biomaterial-injected group corresponds to frequent or consis-
tent plantar stepping with occasional forelimbs-hindlimbs coordi-
nation. The observed difference in locomotor coordination among
treatment and both control groups was statistically relevant
(P,0.05).
Discussion
In a previous study we showed RADA16-4G-BMHP1 to be a
good candidate for nervous tissue engineering as it enhanced in
vitro NSC survival and differentiation [37]. In the current work we
evaluated its neuroprotective and neuroregenerative potential
when injected into the rat acute spinal cord injury.
Overall, the scaffold didn’t show a relevant neuroprotective
effect, as we didn’t observe an attenuation of inflammatory
processes nor a lesser extent of cyst and cavities in treated animals
compared to untreated ones. On the other hand, the presence of
the functionalized biomaterial didn’t elicit an important immune
response as, with the exception of IL-6 and TACE whose mRNA
levels were upregulated only in the treatment group, the other
inflammatory factors TNFa, iNOS and nNOS were found
upregulated in both biomaterial and saline injected groups. This
observation indicates that the injection procedure, even if less
invasive than other implantation techniques [8,52], can have
induced a tissue loss and cell death due to needle insertion and can
be then resulted in a slight increment of the sub-acute
inflammatory response. The increment of IL-6 and TNFa mRNA
expression can explain also the increment of GFAP and BMP2
mRNA expression seen in biomaterial and saline injected groups,
because these pro-inflammatory cytokines induce the activation
and migration of microglia and astrocytes [53]. TNFa also
upregulates the expression of BMP2 in astrocytes [54]. However,
the observed increment of mRNA expression of pro-inflammatory
and pro-astrogliosis genes at 7 dpi didn’t lead to relevant
anatomopatological changes at 8 weeks after SCI. As matter of
fact, histological analysis revealed the presence of the glial scar and
of several macrophages infiltrating the lesion area in treatment and
both control groups. Of note, at this time astrocytes appeared to
border the cavity but not to infiltrate the scaffold. The high
number of macrophages we measured at 8 weeks in all groups was
similar to the value that is generally assessed in the acute phase of
SCI [53], but others authors have showed in rats the presence of a
second peak in the macrophage/microglial response at 60 days
after moderate contusion [55]. Thus the quantity of macrophages
we observed may correspond to the second peak occurring in the
animal model we used.
In conjunction with the upregulation of mRNA expression of
pro-inflammatory cytokines, at 7 dpi in the treatment group we
observed also a higher mRNA expression of the proteolytic
activators (MMP-3 and MMP-14) of MMP-9 and MMP-2 and a
corresponding downregulation of two inhibitors (TIMP-1 and
THBS-2) of these proteases, suggesting that the scaffold promoted
the MMPs activity. MMPs are secreted by activated astrocytes,
microglia and macrophages, which after a CNS damage are
induced by cytokines, comprising TNFa, to produce the proforms
of MMPs and their activators (other proteases or free radicals)
[44]. During the acute phase of SCI, MMP-2 and MMP-9 play a
critical role in the disruption of the blood-spinal cord barrier,
resulting in inflammatory cells infiltration, hemorrhage and edema
[56], but successively they participate in reparative processes like
ischemia-induced angiogenesis and neurite outgrowth [45,46].
These regenerative effects displayed by MMPs in the sub-acute
and chronic phases of SCI well correlate with the higher mRNA
levels of GAP-43 and VEGF we found at 7 dpi in the treatment
group in comparison with controls. VEGF is a potent stimulator of
angiogenesis and has been showed to provide a neuroprotective
effect in experimental models of SCI [43]; notably, many
researchers have demonstrated a correlation between VEGF
release and MMP-2 and MMP-9 expression [45,56,57]. Thus the
scaffold could have induced a bigger expression of TNFa and its
Gene name Accession n.
1 Primer Sequence 59–39
Amplicon
length (bp) Cycle
2
R: tcctctacaatgacggtttcct
1NCBI accession number of mRNA and corresponding gene, available at http://www.ncbi.nlm.nih.gov/gene.
2cycle number corresponding to the exponential phase of amplification of the PCR product using 50 ng of cDNA.
doi:10.1371/journal.pone.0019782.t001
Table 1. Cont.
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PLoS ONE | www.plosone.org 6 May 2011 | Volume 6 | Issue 5 | e19782Figure 2. Quantitative histological analysis in the chronic phase of SCI. (A): lesion size was quantified on spinal cord longitudinal sections
stained with hematoxylin/eosin (Ai) and it was reported as cumulative area (mm
2). No significant differences among groups were found when
measuring both the whole cyst area (Aii) and the cavities into the cyst area (Aiii). Scale bar =800 mm. (B): GAP-43 positive fibers (Bi and Biii, red) were
measured on six longitudinal sections after immunofluorescence staining and the values were expressed as percentage of the total area of the cyst.
The GAP-43 immunopositive area was significantly higher in biomaterial-treated group (4G-BMHP1) than both control groups (saline and SCI control)
(Bii). In Biii the positive GAP-43 signal is showed at higher magnification (asterisk and dotted line indicate the cyst and its border, respectively). Scale
bar =400 mm in Bi, 50 mm in Biii. (C): CD68 positive cells (Ci and Ciii, green) were counted on three longitudinal sections after immunofluorescence
staining and reported as cumulative number per mm
2. Nuclei were counterstained with DAPI. Macrophage infiltration was observed in the tissue
surrounding the cyst and into the cavities of all groups (Cii). In Ciii, at higher magnification, we reported an image representative of the CD68 positive
cells (arrows) we observed in all groups. Scale bar =400 mm in Bi, 100 mm in Biii. Values represent means 6 SEM. Significance symbols: * p,0.05, 4G-
BMHP1 vs SCI control; u p,0.05, 4G-BMHP1 vs saline.
doi:10.1371/journal.pone.0019782.g002
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PLoS ONE | www.plosone.org 7 May 2011 | Volume 6 | Issue 5 | e19782Figure 3. Evaluation of mature and immature nerve fibers infiltrating the cyst. Images show the cyst cavity in SCI control, saline injected
and 4G-BMHP1 treated animals at 8 weeks after lesion. Asterisks indicate the scaffold. Immunolabelling for GAP-43 (red) coupled with SMI-31 (green)
or SMI-32 (green) was made on longitudinal sections. Nuclei were counterstained with DAPI. Within the cyst, the majority of GAP-43
+ sprouting/
growing axons consisted of immature fibers expressing the non-phosphorylated neurofilament H (SMI-32
+), even if also GAP-43
+ mature fibers,
staining for the phosphorylated neurofilament H (SMI-31
+), were observed. The percentage of GAP-43
+ fibers expressing either SMI-32 or SMI-32
appeared similar in all groups. Scale bar =200 mm.
doi:10.1371/journal.pone.0019782.g003
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last, in induction of pro-angiogenic events. However, 8 weeks after
SCI the histological analysis revealed a similar density of vWF
positive blood vessel among groups, even if in treated animals
blood vessels converged on the implant, suggesting that it could
work as trophic and mechanical support for vessels. Of note, in the
treatment group we observed a bigger deposition of laminin and
type IV collagen, that were present also within the implants. In
experimental models of SCI it has been reported that basal lamina
plays a role in preventing CNS axon regeneration [58], but in
human SCI it has been displayed that type IV collagen and
laminin, two components of basement lamina, were mostly
produced by migrating Schwann cells and fibroblasts and that
basal lamina supported outgrowth of peripheral nervous system
Figure 4. Evaluation of gliotic and angiogenic processes within the lesion area. From the left to the right, arrows indicate blood vessels
(vWF+, red) infiltrating the lesion area, collagen IV deposition (red) within the cyst and the glial scar (GFAP+, green) surrounding the lesion site.
Asterisks indicate the scaffold. Nuclei were counterstained with DAPI. Blood vessels infiltration appeared similar in all groups, but in the treatment
group (4G-BMHP1) a greater deposition of type IV collagen occurred. Several GFAP+ astrocytes surrounding the cyst margins and infiltrating the
lesion were observed in all groups but they were not detected within the scaffolds. Scale bar =400 mm. 2
doi:10.1371/journal.pone.0019782.g004
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colleagues, after implantation of collagen, fibrin or fibronectin
gels into the damaged rat spinal cord, observed that within the
implants the laminin deposition often took a tubular appearance
and that the majority of these laminin positive tubules were not
associated with blood vessels but with axons, suggesting a role of
the laminin for axonal guidance [52,60]. By histological analysis
we obtained similar results: within implants and cavities the
laminin and type IV collagen were rarely found along blood
vessels (marked with vWF) whereas they were often found in
association with b-TubIII positive nerve fibers. Interestingly,
within the scaffold we observed not only laminin deposition but
also laminin positive cells surrounding axons, suggesting the
presence of invading Schwann cells migrated from dorsal roots
[50]. As already described by Tsiper and colleagues [61], on the
surface of these laminin positive cells an accumulation of type IV
collagen was also found.
Another important protein that we found upregulated at 7 dpi
in biomaterial-treated animals was GAP-43. The higher GAP-43
mRNA levels compared to controls can be explained by the
concurrent increased mRNA expression, in the treatment group,
of MMPs activators, as these proteases can have potentially
beneficial effects on axonal regeneration after SCI: MMPs favour
axon regeneration by degrading various inhibitory extracellular
proteins and their expression is correlated with areas of increased
axonal outgrowth after CNS injury [46]. Of interest the
overexpression of GAP-43 mRNA at 7 dpi resulted in an
increased immunopositivity to GAP-43 at 8 weeks: in treated
Figure 5. Immunofluorescence analysis of cellular and non-cellular infiltrates into the injected scaffold. (A) and (B): arrows indicate
collagen IV+ cells (A, red) and NG2+ cells (B, red), whereas arrowheads indicate GFAP+ glial cells (A and B, green). (C): arrows show IBA+ microglia cells
(red) and arrowheads CD68+ macrophages (green). (D) and (E): arrows indicate b-TubIII
+ axons (green) surrounded by the basement membrane,
composed by collagen IV (D, red) and laminin (E, red); arrowheads show collagen IV+ (D) and laminin+ (E) cells. Asterisks indicate the scaffold. Nuclei
were counterstained with DAPI. A remarkable deposition of type IV collagen and laminin was observed into the biomaterial and specifically along
axons. The non-neuronal cellular infiltrate was mainly represented by Iba-I
+ microglia cells and NG2
+ oligodendrocyte precursor cells, whereas GFAP
+
astrocytes and CD68
+ macrophages mostly surrounded the implant. Into the scaffold we also observed cells showing type IV collagen and laminin
immunopositivity, strictly coupled to axons, likely ascribable to Schwann cells. Scale bar =100 mm.
doi:10.1371/journal.pone.0019782.g005
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augmented more than twofold in comparison to controls. GAP-43
is a major constituent of the growth cones and plays an important
role in axonal regeneration after CNS injury [62], but it seems not
to be a sufficient determinant to promote axonal outgrowth [38].
Thus to explain the supplementary axonal sprouting and/or
Figure 6. Immunofluorescence analysis of neuronal elements and nerve fibers within the scaffold. (A): the scaffold was infiltrated by
neuronal cells (b-TubIII
+, green) and sprouting/regenerating nerve fibers, that were positive for both GAP-43 (red) and b-TubIII (green). Merge of two
stainings is reported at higher magnification on the right, arrows indicate some axons expressing both GAP-43 and b-TubIII. Scale bar =100 mm for
images on the left and 50 mm for image on the right. (B): co-staining for b-TubIII (red) and MBP (green) revealed that some sprouting/regenerating
fibers were myelinated, as seen on the right in the merge or below in the high-magnified inserts, where myelin surrounding some GAP-43
+ axons is
visible (Bi, arrows). Scale bar =100 mm for images on the left, 50 mm for image on the right and 20 mm for images below. Nuclei were counterstained
with DAPI.
doi:10.1371/journal.pone.0019782.g006
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scaffold could have promoted not only an overexpression of GAP-
43 but also a growth permissive environment around and into the
lesion site. This hypothesis is supported by the observed elevation
at 7 dpi in biomaterial-injected animals of mRNA levels of CNTF,
a trophic factor having neuroprotective effects in hemisection or
contusion models [41]. Moreover the scaffold can have constituted
a physical support for growing axons into the cyst, as suggested by
the presence of several infiltrating neural fibers within the implant.
Further histological analyses revealed that some of GAP-43
positive fibers found into the scaffold were myelinated. In addition
we examined the phosphorylation state of neurofilament H
proteins, as a marker of axonal maturity, and we found both
immature (SMI-32
+) [48] and mature (SMI-31
+) [49] fibers.
Besides allowing nerve fibers ingrowth and basement membrane
deposition, histological analysis revealed that the biomaterial
promoted also migration of cellular elements, mainly composed by
microglia cells, neuronal cells and, interestingly, NG2 positive
cells. NG2 expressing cells are an endogenous cell population that
are thought to play a role in generating new oligodendrocytes after
CNS injury [63] and it has been demonstrated by Kim and
colleagues that these cells proliferate and differentiate into
oligodendrocytes after delivery of VEGF to the injured spinal
cord tissue [43]. In the light of these studies, the myelin that we
observed around few axons infiltrating the implant could have
been produced, other than by migrating Schwann cells, by
oligodendrocytes derived from the differentiation, probably
enhanced by VEGF, of NG2 positive precursor cells.
The nervous tissue ingrowth enhanced by the scaffold resulted
in a slight but statistically significant improvement of both
hindlimbs motor performance and forelimbs-hindlimbs coordina-
tion in biomaterial-injected group in comparison to the sponta-
neous recovery observed in both control groups. As this difference
appeared around one week before sacrifice of animals, it could be
useful in future experiments to prolong the observation period of
other weeks in order to follow the progress of this gap among
groups.
Altogether, the results of the present study indicate that the
injectable SAP based scaffold provided a good substrate enhancing
matrix remodelling, release of trophic factors, cell migration and
basement membrane deposition, resulting at 8 weeks after lesion in
an increased number of regenerating/sprouting axons in compar-
ison to the limited axon outgrowth normally occurring after
incomplete SCI. Moreover the functionalized SAP showed to be
compatible with the surrounding nervous tissue and to be able to
at least partially fill the cavities at SCI site. Thus the
functionalization of RADA16-I with a bone marrow homing
motif, improved by the insertion of a longer glycine-spacer, can
produce a biomimetic scaffold useful for regenerative therapy
applications. Of note, as RADA16-I based scaffolds have been
successfully used for NSCs culture and differentiation [33,37] and
for the sustained release of active cytokines [20,36], RADA16-4G-
BMHP1 could also constitute a good matrix for the in vivo delivery
of growth factors and/or NSCs into the injured CNS.
Materials and Methods
Ethics statement
All procedures involving animals were performed according to
EU Directive (86/609/EEC), to Italian legislation on animal
experimentation (Decreto L. vo 116/92) and to protocols
approved by the Animal Care and Use Committee of the
University of Milano-Bicocca.
SAP synthesis and purification
SAPs were prepared as previously reported [36]. Briefly, the
peptide RADA16-I-4G-BMHP1 (Ac-RADARADARADARA-
DAGGGGPFSSTKT-CONH2) was F-moc synthesized via a
Liberty microwave automated synthesizer (CEM, Matthews
USA). Sample masses were verified via a MALDI-TOF mass-
spectrometer (Applied biosystems, Carlsbad, California), HPLC
purified (Waters, Milford Massachusetts), and lyophilized (Lab-
conco, Kansas City Missouri). Trifluoroacetic acid salts, arising
from synthesis and purification of SAPs, were replaced with Cl
salts via dissolution in 0.1 M HCl solution. SAPs were lyophilized
and dissolved at 1% (w/v) concentration in sterile distilled water
(Gibco). SAP solution was sonicated for 30 min prior to usage.
Experimental groups
We randomly divided 45 female Sprague-Dawley rats weighing
220–250 g (Charles River Laboratories) into 3 groups as follows: 1)
animals receiving only contusion (SCI control group) (N=15);
2) animals receiving contusion and injection of saline alone (saline
control group) (N=15); 3) animals receiving contusion and
injection of SAPs (4G-BMHP1 treatment group) (N=15). For
each experimental group, 8 animals were used for gene expression
analysis and sacrificed 3 or 7 dpi, while 7 animals were used for
histological analysis and sacrificed 8 weeks after injury.
SCI induction and biomaterial delivery
Rats were anesthetized with an intraperitoneal injection of
ketamine (80 mg/kg) and xylazine (10 mg/kg). After laminectomy
at T9-T10 level, the exposed spinal cord was lesioned by a 10-g rod
dropped from height of 25 mm by using a MASCIS Impactor
device (WM Keck Center for Collaborative Neuroscience, Rutgers
University), as previously described [64]. Injury induced by the
impactor at this height corresponds to a moderate lesion in the
Figure 7. Evaluation of locomotor recovery over 8 weeks after
SCI. BBB rating scale ranges from a minimum of 0 (no observable
hindlimbs movements) to a maximum of 21 (presence of consistent
plantar stepping, coordination and trunk stability). At 7.5 weeks after
injury, in the treatment group (4G-BMHP1) we observed a better
improvement of hindlimbs motor recovery compared to both control
groups (saline and SCI control). This statistically relevant difference
among scores implies that all groups had frequent or consistent plantar
stepping but in the treatment group occurred also an occasional
forelimbs-hindlimbs coordination. Values represent means 6 SEM.
Significance symbols: * p,0.05, 4G-BMHP1 vs SCI control; u p,0.05, 4G-
BMHP1 vs saline.
doi:10.1371/journal.pone.0019782.g007
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were monitored and recorded to guarantee consistency among
animals. Immediately after injury, animals were injected either with
RADA16-I-4G-BMHP1 (1% aqueous solution) or saline using an
Hamilton syringe (33-gauge needle) fixed at a micromanipulator:
the dura mater located on the injury site was opened by performing
a longitudinal cut, then either SAPs or saline was delivered into the
spinal cord lesion at 3 intervals ranging about 500 mm, and at each
interval two injections of 0,5 ml each were made, for a total dose of
3 ml (Figure 8Aii-Aiii). After injection, the syringe was left in the
cord for 5 min, then the needle was withdrawn, the muscles were
sutured and finally the skin was closed with wound clips. Rats were
treated daily for one week with analgesic (carprofen, 5 mg/kg) and
antibiotic (enrofloxacin, 5 mg/kg). Animals were monitored for
autophagiaand theirbladderwasmanuallyexpresseduntilrecovery
of the voiding reflex.
Behavioral tests
Hindlimbs recovery was assessed by using the Basso, Beattie,
Bresnahan (BBB) Locomotor Rating Scale [51]. Starting from 1
week post injury, every 3–4 days each rat was observed and
recorded with a digital video camera for 4 min in an open field.
Gene expression analysis
Semi-quantitative RT-PCR was employed to evaluate mRNA
expression of genes of interest. For each time point studied - 3 and
7 dpi- 4 animals from each group were used.
Rats were anesthetized by an overdose of avertin (400 mg/kg)
and sacrificed. A 1 cm-length of the spinal cord centered at the
injury site was removed, snap-frozen in liquid nitrogen and stored
at 280uC until further processing.
Total RNA was extracted using Trizol
TM Reagent (Invitrogen)
and treated with DNase-I, Amplification Grade (Invitrogen)
according to manufacturer’s protocols. Integrity of each sample
was examined by agarose gel electrophoresis. Before and after
DNase-I digestion, total RNA was quantified using the Nano-
DropH ND-1000 spectrophotometer.1mg of total RNA was
used for cDNA synthesis using the SuperScript
TM III Reverse
Transcriptase kit (Invitrogen) according to the manufacturer’s
protocol.
Primers sequences were obtained from others publications
[65,66] or designed on the basis of gene and mRNA sequences
available online (http://www.ncbi.nlm.nih.gov/gene). Primer
design was performed using Primer3 free software (http://frodo.
wi.mit.edu/primer3/). Primers were designed to be intron-
spanning when possible. For each primer couple we first esta-
blished the cycle number corresponding to the exponential phase
of amplification of the PCR product. This evaluation was done on
50 ng of cDNA derived from intact or lesioned spinal cord tissue
and PCR was performed as described below. In Table 1 we
reported, for each gene of interest, forward (F) and reverse (R)
primer sequence and their NCBI accession number, amplicon
length and cycle number at the exponential phase.
PCR was carried out by using Taq DNA Polymerase,
recombinant (Invitrogen) in a total volume of 25 ml containing
50 ng of cDNA and 10 mM of sense and antisense gene-specific
primers. The amplification products were analyzed by electro-
phoresis on a 2% agarose gel in 1x TAE buffer (40 mM Tris–
acetate and 1 mM EDTA) containing 0.5 mg/ml ethidium
bromide. Gel images were captured using the KODAK Gel Logic
200 Imaging System.
The relative expression of genes was determined by measuring
the band intensity and using cyclophilin A as housekeeping [67].
The quantification procedure based on digitalization of the PCR
product after separation on agarose gel provides a well-established
and sensitive method to detect even small differences in amounts
of mRNA from different biological samples [68]. The densito-
metric analysis of bands was performed using the LabImage 1D
software (Kapelan). To minimize variations among gels, each band
intensity was first divided by the band intensity of the 500 bp
fragment of a 100 bp DNA ladder (New England BioLabs), then
the relative level of mRNA expression was calculated by dividing
the band intensity of each gene by the band intensity of the
housekeeping gene, as previously described [69].
Histochemical and immunofluorescence analysis
Eight weeks after injury 5 rats from each group were deeply
anesthetized with an overdose of avertin (400 mg/kg) and
sacrificed by transcardial perfusion with 4% paraformaldehyde
in PBS. The spinal cord segment spanning between T8 and T12
was taken, post-fixed in 4% paraformaldehyde, cryoprotected in
sucrose, embedded in OCT compound and frozen. Longitudinal
sections (16 mm thickness) were serially collected on a freezing
microtome and stored at 220uC.
For histochemical analysis slices were processed with hematox-
ylin-eosin staining.
Figure 8. Delivery of the biomaterial into the damaged rat spinal cord. Rat spinal cord was exposed at T9-T10 level and subjected to
moderate contusion using MASCIS impactor (Ai), then animals were injected with the biomaterial using an Hamilton syringe fixed at a
micromanipulator (Aii, arrow indicates the needle penetrating into the injury site). The needle was inserted until reaching the ventral surface of the
spinal cord then, starting from this position, the biomaterial was delivered into the lesion epicenter with multiple injections equally spaced of
approximately 500 mm, for a total dose of 3 ml (Aiii).
doi:10.1371/journal.pone.0019782.g008
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permeabilized with 0,1% Triton X-100 and blocked with 10%
normal goat serum. Afterward, the following primary antibodies
were applied overnight at 4uC: anti-SMI-32 (1:1000, Covance,
SMI-32R); anti-SMI-31 (1:1000, Covance, SMI-31R); anti-bIII-
Tubulin (b-TubIII) (1:400, Covance, MMS-435P or PRB-435P);
anti-myelin basic protein (MBP) (1:350, Covance, SMI-99P); anti-
growth associated protein 43 (GAP-43) (1:200, Millipore,
AB5220); anti-Von Willebrand factor (vWF) (1:500, DakoCyto-
mation, P0226); anti-glial fibrillary acidic protein (GFAP) (1:500,
Millipore, MAB3402); anti-NG2/ chondroitin sulfate proteogly-
can (1:200, Millipore, AB5320); anti-laminin (1:200, Sigma-
Aldrich, L9393); anti-collagen IV (1:100, Cedarlene, CL50-
441AP); anti-CD68 (1:500, Serotec, MCA341R) and anti-Iba-I
(1:1000,Wako, 019-19741). The slides were washed in PBS three
times, primary antibodies were then probed with Cy3- (1:1000,
Jackson) or Alexa 488- (1:500, Invitrogen) conjugated secondary
antibodies. Sections were washed in PBS three times, counter-
stained with DAPI and mounted with FluorSave reagent
(Calbiochem).
Brightfield and fluorescence images were acquired with Zeiss
Axioplan 2 microscope or, for images at high magnification in z-
stacking, with Zeiss ApoTome Microscope.
Quantification of the lesion size, macrophage infiltration and
axonal sprouting/regeneration at the injury site was performed on
longitudinal sections using Image J software (available: http://rsb.
info.nih.gov/ij/) as described below. Sections started from the
dorsal surface of the spinal cord and were spaced 160 mm.
Cavities size was quantified in seven-to-sixteen sections per
animal, depending on the cyst extent. Sections were stained with
hematoxylin/eosin and images were captured at 5x magnification,
then single images were jointed with Photoshop in order to obtain
an image of the whole cyst. The resulting image was then
processed with Image J software: the cyst area was selected, the
colour image was converted in binary image and the content of
positive pixels was measured in order to quantify cavities size into
the cyst. Also the whole cyst size was measured. Pixel area was
converted to mm
2 and measurements of either the whole cyst or
cavities into the cyst of all sections were summed to produce the
cumulative area of each animal.
Macrophage infiltration within the lesion area was quantified in
three sections per animal. After immunofluorescence staining for
CD68 and labeling of nuclei with DAPI, images were captured at
20x magnification. For each section, 16 images of the cyst area
were taken for a total of 2.3 mm
2. Cells count of CD68 positive
inflammatory cells was made with Image J. The average of the
measurements performed in three sections constituted the value of
the number of macrophages/mm
2 of each animal.
GAP-43
+ sprouting/regenerating axons were quantified in six
sections per animal. After immunofluorescence staining for GAP-
43, images of the whole cyst area were captured at 20x
magnification. Images were jointed with Photoshop and processed
with Image J: the cyst area was selected, the colour image was
converted in binary image and the content of positive pixels was
measured in order to quantify the GAP-43 positive area into the
cyst. The mean of the six measurements, expressed as percentage
of the total area of the cyst, constituted the value of the axonal
regeneration of each animal.
Statistical analysis
Data were processed using GraphPadPrism 5 software. Values
were reported as means 6 standard error of the mean (SEM). For
BBB scores and gene expression analysis, multiple and pairwise
comparisons among groups were performed by one-way ANOVA
and Tukey test.
For quantification of the cavity size, macrophage infiltration
and axonal regeneration, comparison between the treated group
and each control group was made by Mann-Whitney test. All
analyses were two-tailed and p values ,0.05 were considered as
statistically significant.
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